Brokerages predict that Steris PLC (NYSE:STE) will post $1.11 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Steris’ earnings. The lowest EPS estimate is $1.11 and the highest is $1.12. Steris reported earnings per share of $1.00 during the same quarter last year, which would suggest a positive year-over-year growth rate of 11%. The business is scheduled to announce its next quarterly earnings results on Wednesday, August 14th.

On average, analysts expect that Steris will report full-year earnings of $5.37 per share for the current financial year, with EPS estimates ranging from $5.35 to $5.40. For the next year, analysts expect that the business will report earnings of $5.93 per share, with EPS estimates ranging from $5.90 to $5.99. Zacks’ EPS averages are a mean average based on a survey of sell-side research firms that follow Steris.

Steris (NYSE:STE) last announced its earnings results on Monday, May 13th. The medical equipment provider reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.44 by $0.09. The business had revenue of $768.00 million for the quarter, compared to the consensus estimate of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. Steris’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period last year, the firm posted $1.24 earnings per share.

STE has been the topic of a number of recent research reports. Zacks Investment Research cut shares of Steris from a “hold” rating to a “sell” rating in a research report on Wednesday, April 24th. KeyCorp increased their price target on shares of Steris from $135.00 to $138.00 and gave the company an “overweight” rating in a research report on Wednesday, May 15th. JMP Securities increased their price target on shares of Steris from $135.00 to $150.00 and gave the company a “market outperform” rating in a research report on Wednesday, May 22nd. Finally, Stephens increased their price target on shares of Steris from $135.00 to $150.00 and gave the company an “overweight” rating in a research report on Wednesday, May 15th. Five investment analysts have rated the stock with a buy rating, Steris has an average rating of “Buy” and an average price target of $148.20.

In other news, Director Jacqueline B. Kosecoff sold 3,609 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The shares were sold at an average price of $132.22, for a total value of $477,181.98. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP John Adam Zangerle sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was sold at an average price of $131.77, for a total transaction of $197,655.00. The disclosure for this sale can be found here. Insiders sold 244,145 shares of company stock worth $33,121,338 in the last 90 days. Company insiders own 2.36% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Zions Bancorporation N.A. bought a new position in shares of Steris in the second quarter worth approximately $328,000. WINTON GROUP Ltd grew its holdings in shares of Steris by 82.0% in the second quarter. WINTON GROUP Ltd now owns 10,479 shares of the medical equipment provider’s stock worth $1,560,000 after purchasing an additional 4,720 shares during the last quarter. Park National Corp OH bought a new position in shares of Steris in the second quarter worth approximately $210,000. GYL Financial Synergies LLC bought a new position in shares of Steris in the first quarter worth approximately $840,000. Finally, Fort L.P. grew its holdings in shares of Steris by 23.6% in the first quarter. Fort L.P. now owns 19,561 shares of the medical equipment provider’s stock worth $2,504,000 after purchasing an additional 3,733 shares during the last quarter. Hedge funds and other institutional investors own 83.38% of the company’s stock.

STE traded down $2.72 on Wednesday, reaching $149.77. The company had a trading volume of 298,846 shares, compared to its average volume of 480,460. Steris has a 52-week low of $99.14 and a 52-week high of $154.09. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.82 and a current ratio of 2.27. The business has a 50 day moving average of $141.93. The stock has a market capitalization of $12.92 billion, a P/E ratio of 30.63 and a beta of 1.00.

The company also recently announced a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Wednesday, June 12th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.91%. The ex-dividend date of this dividend was Tuesday, June 11th. Steris’s dividend payout ratio is 27.81%.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Further Reading: Understanding Analyst Recommendations

Get a free copy of the Zacks research report on Steris (STE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.